CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-24 | Titterton Lewis H jr Director | Option exercise | +30,000 | $2.58 | $77K | 1,018,070 |
| 2022-06-24 | Titterton Lewis H jr Director | Option exercise | +16,000 | $2.58 | $41K | 1,034,070 |
| 2022-06-24 | Titterton Lewis H jr Director | Option exercise · Employee Stock Option | −30,000 | 0 | ||
| 2022-06-24 | Titterton Lewis H jr Director | Option exercise · Employee Stock Option | −16,000 | 0 | ||
| 2022-04-29 | Catelani Michael President | Other acquisition | +1,086 | $2.76 | $3K | 19,221 |
| 2022-04-26 | Titterton Lewis H jr Director | Purchase | +10,000 | $2.79 | $28K | 988,070 |
| 2022-04-21 | Catelani Michael President | Purchase | +5,500 | $2.66 | $15K | 18,135 |
| 2022-04-20 | Catelani Michael President | Purchase | +2,509 | $2.53 | $6K | 12,635 |
| 2022-04-14 | Catelani Michael President | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-10 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-10 | Catelani Michael COO & CFO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-03-10 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-10 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-03-10 | Baskies Arnold M Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-12 | Titterton Lewis H jr Director | Purchase | +5,000 | $3.28 | $16K | 978,070 |
| 2022-01-11 | Titterton Lewis H jr Director | Purchase | +2,000 | $3.20 | $6K | 973,070 |
| 2022-01-10 | Titterton Lewis H jr Director | Purchase | +6,000 | $3.08 | $18K | 971,070 |
| 2022-01-07 | Titterton Lewis H jr Director | Purchase | +11,000 | $3.08 | $34K | 965,070 |
| 2022-01-07 | KUMAR AMIT Chief Executive Officer | Purchase | +20,000 | $3.00 | $60K | 314,000 |
| 2021-10-29 | Catelani Michael COO & CFO | Other acquisition | +743 | $4.04 | $3K | 10,126 |
Page 6 of 21 · 404 trades